Research Article | Open Access
Wei Gu, Ying Sun, Xiong Zheng, Jin Ma, Xiao-Ying Hu, Tian Gao, Mei-Jie Hu, "Identification of Gastric Cancer-Related Circular RNA through Microarray Analysis and Bioinformatics Analysis", BioMed Research International, vol. 2018, Article ID 2381680, 9 pages, 2018. https://doi.org/10.1155/2018/2381680
Identification of Gastric Cancer-Related Circular RNA through Microarray Analysis and Bioinformatics Analysis
Gastric cancer is one of the common malignant tumors worldwide. Increasing studies have indicated that circular RNAs (circRNAs) play critical roles in the cancer progression and have shown great potential as useful markers and therapeutic targets. However, the precise mechanism and functions of most circRNAs are still unknown in gastric cancer. In the present study, we performed a microarray analysis to detect circRNA expression changes between tumor samples and adjacent nontumor samples. The miRNA expression profiles were obtained from the National Center of Biotechnology Information Gene Expression Omnibus (GEO). The differentially expressed circRNAs and miRNAs were identified through fold change filtering. The interactions between circRNAs and miRNAs were predicted by Arraystar’s home-made miRNA target prediction software. After circRNA-related miRNAs and dysregulated miRNAs were intersected, 23 miRNAs were selected. The target mRNAs of miRNAs were predicted by TarBase v7.0. Gene ontology (GO) enrichment analysis and pathway analysis were performed using standard enrichment computational methods for the target mRNAs. The results of pathway analysis showed that p53 signaling pathway and hippo signal pathway were significantly enriched and CCND2 was a cross-talk gene associated with them. Finally, a circRNA-miRNA-mRNA regulation network was constructed based on the gene expression profiles and bioinformatics analysis results to identify hub genes and hsa_circRNA_101504 played a central role in the network.
Gastric cancer is one of the common malignant tumors in the clinic, with the second leading cause of cancer-related death worldwide [1, 2]. Although the treatment of gastric cancer has gradually improved, cure rate of gastric cancer is still low. With a lack of obvious clinical symptoms at early stage, most patients have lost the opportunity of surgical therapy when gastric cancer is detected at advanced stage . Recurrence is the chief cause of gastric cancer-related death. According to recent statistics, more than 30% of patients suffering from stage III gastric cancer who undergo surgical resection develop recurrence or distant metastasis with a 14-month median recurrence-free survival time [4, 5]. Therefore, prevention and cure of gastric cancer are still challenged in the clinic and the search for new molecular markers to monitor and intervene in gastric cancer carcinogenesis is urgent.
Recent research has shown that circular RNAs (circRNAs) play a critical role in the initiation and progression of human diseases especially in tumors and may function as potential molecular markers for disease diagnosis and treatment . Circular RNAs are a class of endogenous noncoding RNAs, characterized by their covalently closed-loop structures without a 5′ cap or a 3′ Poly(A) tail. Previous studies demonstrated that circRNAs existed widely in all kinds of organizations [7–9] and played a strong regulatory function in cancer [10, 11]. For example, circRNAs are dysregulated in epithelial tumors, such as laryngeal cancer and digestive system cancers [12–14], and in stromal tumors, such as gliomas . Compared with mRNAs, circRNAs are more stable due to the existence of ring structure. Thus, circRNA can serves as a convenient tool for qRT-PCR measurements in cancer.
CircRNAs have been investigated for more than 40 years , but they have been considered as a result of splicing errors for several decades and their biological functions are largely unknown. With the development of RNA sequencing (RNA-seq) technologies and bioinformatics, circRNAs have been extensively explored in recent years and several functions of circRNA have been revealed, such as acting as scaffolds in the assembly of protein complexes , sequestering proteins from their native subcellular localization , modulating the expression of parental genes , regulating alternative splicing  and RNA-protein interactions , and functioning as microRNA (miRNA) sponges .
Our study aimed to establish the expression profile of gastric cancer through circRNA microarray chip detection. Our results revealed the potential role of circRNAs in gastric cancer. We also aimed to identify the hub circRNAs involved in gastric cancer through bioinformatics analysis. The miRNA expression profiles from the National Center of Biotechnology Information Gene Expression Omnibus (GEO) were used to identify circRNA-related dysregulated miRNAs in gastric cancer. Gene ontology (GO) enrichment analysis and pathway analysis revealed the potential biology function of miRNA target genes. Finally, a circRNA-miRNA-mRNA regulation network was constructed to selected hub genes and we found that hsa_circRNA_101504 played a central role in the network.
2.1. Clinical Samples
Six pairs of tumor and adjacent nontumor tissues were obtained from patients with gastric cancer who underwent surgery at the Ruijin Hospital, Shanghai Jiaotong University School of Medicine, between May 2011 and May 2014. None of the patients had received neoadjuvant therapy, and the samples were pathologically confirmed postoperatively as gastric cancer. The samples were taken within 10 min after tumor excision, immediately immersed in RNAlater® stabilization solution (Thermo Fisher Scientific, Carlsbad, CA, USA) and then stored at −80°C until being used in the experiments. The study was performed in accordance with the ethical standards of the Declaration of Helsinki and was approved by the Ethics Committee of Ruijin Hospital. Informed consent was obtained from all patients participating in the present study.
2.2. circRNA Microarray Analysis
Total RNA from each sample was quantified using the NanoDrop ND-1000. The sample preparation and microarray hybridization were performed based on Arraystar’s standard protocols. Briefly, total RNA from each sample was amplified and transcribed into fluorescent cRNA utilizing random primer according to Arraystar’s Super RNA Labeling protocol (Arraystar Inc.). The labeled cRNAs were hybridized onto the Arraystar Human circRNA Array (6x7K, Arraystar). After having washed the slides, the arrays were scanned by the Axon GenePix 4000B microarray scanner. Scanned images were then imported into GenePix Pro 6.0 software (Axon) for grid alignment and data extraction. Quantile normalization and subsequent data processing were performed using the R software package. Differentially expressed circRNAs with statistical significance between two groups were identified through volcano plot filtering. Differentially expressed circRNAs between two samples were identified through fold change filtering. Hierarchical clustering was performed to show the distinguishable circRNAs expression pattern among samples.
2.3. Annotation for circRNA/miRNA Interaction
Recent evidences have demonstrated that circular RNAs play a crucial role in fine tuning the level of miRNA mediated regulation of gene expression by sequestering the miRNAs. Their interaction with disease associated miRNAs indicates that circRNAs are important for disease regulation. The circRNA/microRNA interaction was predicted with Arraystar’s home-made miRNA target prediction software based on TargetScan  and miRanda , and the differentially expressed circRNAs within all the comparisons were annotated in detail with the circRNA-miRNA interaction information.
2.4. miRNA Datasets and Data Analysis
The original miRNA expression profile of GSE23739 used in the present study was downloaded from the National Center of Biotechnology Information Gene Expression Omnibus (GEO). MicroRNA expression of twenty pairs of tissue samples collected from patients diagnosed with gastric cancer was determined by miRNA microarrays (platform was GPL19071) in this data. Each pair included resected primary tumor and corresponding healthy gastric mucosa. There were no replicates. Differentially expressed miRNAs were identified by using GEO2R. The target genes of differentially expressed miRNAs were predicted by using TarBase v7.0  with a prediction score ≥0.8 and all the miRNA-mRNA interactions were experimentally supported.
2.5. Gene Function Analysis
Gene ontology (GO) enrichment analysis of miRNA target genes was implemented with DAVID (http://david.abcc.ncifcrf.gov/). GO terms (molecular function, biological processes, and cellular components) with value less than 0.05 were considered significantly enriched by differential expressed genes. Kyoto Encyclopedia of Genes and Genomes (KEGG) is a database resource for understanding high-level functions and effects of the biological system (http://www.genome.jp/kegg/). DAVID was also used to test the statistical enrichment of genes or target genes of miRNA with differential expression in KEGG pathways. The networks of the pathways and pathway-related genes were constructed by using Cytoscape (version 3.4.0) plugin ClueGO  + Cluepedia  app.
2.6. Construction of the circRNA-miRNA-mRNA Regulation Network
Significantly expressed circRNAs and miRNAs and predicted mRNAs were superimposed onto the circRNA-miRNA-mRNA network. The network was constructed by using Cytoscape (version 3.4.0) and the network topology was analyzed by using CentiScaPe app .
2.7. Statistical Analysis
Statistical analysis was performed using SPSS 22.0 (Chicago, IL, USA). Significant differential expression levels of circRNAs or miRNAs were analyzed by Student’s -test and FDR filtering was used for comparative analysis. The value ≤ 0.05 and absolute fold change ≥2.0 were considered statistically significant.
3.1. Screening of Differentially Expressed circRNAs and miRNAs
Expression profiling data of 2070 circRNAs were obtained by using circRNA microarray analysis. The circRNA expression levels were normalized to the same order of magnitude prior to the statistical analysis. As shown in a box plot (Figure 1(a)), the median of different samples was almost on the same line after normalization, which showed a great degree of standardization. The scatter plot was used to assess the circRNA expression variation between the two compared groups of samples (Figure 1(b)). With a threshold of value ≤ 0.05 and absolute value of fold change ≥2.0, a total of 440 differentially expressed circRNAs (176 significantly upregulated circRNAs and 264 significantly downregulated circRNAs) were screened (Table S1). Volcano plot was used to visualize differential expression between tumor group and adjacent nontumor group (Figure 1(c)). Hierarchical clustering was performed based on differentially expressed circRNAs to hypothesize the relationships between samples and the result of hierarchical clustering showed a distinguishable circRNA expression profiling among samples (Figure 1(d)). The miRNA expression profile of GSE23739 was analyzed by using the online tool GEO2R. The box plot showed a great degree of standardization (Figure 2). With a threshold of value ≤ 0.05 and absolute value of fold change ≥2.0, a total of 111 differentially expressed miRNAs including 20 upregulated miRNAs and 91 downregulated miRNAs were identified (Table S2).
3.2. Prediction of circRNA-miRNA and miRNA-mRNA Interaction
Differentially expressed circRNAs contain corresponding miRNA binding sites. To facilitate the investigation, the interactions between miRNAs and circRNAs were predicted by Arraystar’s home-made miRNA target prediction software. The circRNAs with an absolute value of fold change ≥5.0 were selected for further analysis and 260 interactions between 53 circRNAs and 187 miRNAs were screened. 23 miRNAs were selected after differentially expressed miRNAs and circRNA-related miRNAs were intersected (Figure 3). The target genes of the 23 miRNAs were predicted by using TarBase v7.0 and 206 interactions between the 23 miRNAs and 150 mRNAs were obtained.
3.3. The GO and KEGG Enrichment Analysis of the Target Genes
GO and KEGG enrichment analysis were performed for the selected 150 mRNAs to investigate the biological function of the circRNAs. In GO analysis, all the results were ranked by enrichment score and top 10 of every category were displayed in Figure 4. In the biological process analysis, anterior/posterior pattern specification, liver development and transcription, and DNA-templated were the top 3 enriched terms. In the cellular component analysis, cytoplasmic stress granule, cytosol, and nucleoplasm were the top 3 enriched terms. In the molecular function analysis, protein binding, protein kinase binding, and sequence-specific DNA binding were the top 3 enriched terms. Results of KEGG pathway analysis were also ranked by enrichment score and the top 10 pathways associated with the mRNAs were listed in Figure 5(a). The network composed of the most enriched pathways and their related genes (Figure 5(b)) showed that PARD6B, GSK3B, CCND2, CCNE1, PPP2CA, and CDC27 were cross-talk genes associated with at least two pathways.
3.4. Construction of the circRNA-miRNA-mRNA Regulation Network
A circRNA-miRNA-mRNA network was constructed to reveal the interactions in circRNA, miRNA, and mRNA. As shown in Figure 6, hsa-miR-27a-3p had the most degrees and has_circRNA_101504 had the most interactions with miRNAs, indicating that they were hub genes in the regulation network. Dramatically, hsa-miR-93-5p and hsa-miR-20b-5p and hsa-miR-454-3p and hsa-miR-301a-3p were coupled miRNAs which had almost the same target genes. These coupled miRNAs might coregulate the target genes in the network. In graph theory, betweenness centrality is a measure of centrality in a graph based on shortest paths and devised as a general measure of centrality. A node with higher betweenness centrality would have more control over the network, because more information will pass through that node. The DEGs involved in the PPI network (betweenness > 4000) were listed in Table 1.
Gastric cancer is one of the deadliest solid tumors characterized by complex molecular and cellular heterogeneity. Over the past few decades, great efforts have been made to provide novel insights into the molecular mechanisms underlying gastric cancer, but the focus has been on protein-coding genes or miRNAs [28, 29]. Recently, circRNAs has been widely reported to participate in a wide range of biological processes and their dysregulated expression is associated with many complicated human disease phenotypes including cancers [30, 31].
In this study, microarray analysis was performed to obtain the expression profiles of circRNAs in gastric cancer samples and nonmalignant pancreas samples. The expression profiles of miRNAs were obtained from GEO databases and analyzed by using GEO2R. With a threshold of value < 0.05 and absolute fold change ≥2.0, dysregulated circRNAs and miRNAs were identified separately. After the circRNA-related miRNAs dysregulated miRNAs were intersected, 23 miRNAs were selected for further study. Gene function analysis including GO analysis and KEGG pathway analysis was conducted for the target mRNAs of the selected miRNAs. The results of KEGG pathway analysis indicated that p53 signaling pathway and hippo signaling pathway were significantly enriched. P53 is a well-known tumor suppressor gene and the p53 mutations have been reported in many cancers [32, 33]. In gastric cancer, He et al.  found that Fra-1 was upregulated in gastric cancer tissues and played its function by affecting the PI3K/Akt and p53 signaling pathway. Hippo signaling pathway is a newly discovered and conserved signaling cascade, first identified in drosophila . Hippo signal pathway regulates organ size control by governing cell proliferation and apoptosis and is reported to be a tumor-suppressive signal pathway. As shown in Figure 5(b), CCND2 is an important cross-talk gene associated with cell cycle, p53 signaling pathway, and hippo signal pathway. CCND2 also has a high betweenness centrality in the PPI network, indicating that CCND2 might be a bridge of a lot of interactions. For example, CCND2 is a bridge of the target genes of hsa-miR-15a-5p and hsa-miR-93-5p. Zhang et al.  have reported that miR-206 could inhibit gastric cancer proliferation in part by repressing CCND2. Meanwhile, another study showed that dysregulation of miR-206-CCND2 axis might contribute to the aggressive progression and poor prognosis of human gastric cancer in clinical settings. Combined detection of their expression might be particularly helpful for surveillance of disease progression and treatment stratification . However, the relationship between circRNA and CCND2 is still unknown. In the circRNA-miRNA-mRNA regulation network (Figure 6), we revealed that CCND2 might be regulated by hsa_circRNA_105039 and hsa_cirRNA_104682 through hsa-miR-15a-5p and hsa_circRNA_105039 separately. We also found that hsa_circRNA_101504 played a central role in the regulation network. As circRNAs can serve as a competitive endogenous RNA (ceRNA) to sponge miRNAs to regulate the target mRNAs [38, 39], upregulation of hsa_circRNA_101504 might affect several mRNAs by downregulating hsa-miR-454-3p and hsa-miR-301a-3p. In chondrosarcoma, increasing hsa-miR-454-3p can downregulate Stat3 and Atg12 to inhibit chondrosarcoma growth . But, in human glioma, hsa-miR-454-3p has the opposite effect that the prognosis of glioma with high hsa-miR-454-3p expression is significantly worse compared with that of glioma with low hsa-miR-454-3p expression . Therefore, more studies of hsa-miR-454-3p involved in gastric cancer are needed.
In conclusion, we have screened several dysregulated circRNAs through microarray analysis and annotated their function in gastric cancer by bioinformatics analysis. We will gather more clinical samples and validate our findings in future work.
Conflicts of Interest
The authors declare that there are no conflicts of interest.
Wei Gu and Ying Sun are equal contributors to this work.
The authors thank CloudSeq Inc. for the bioinformatic support.
Table S1: differentially expressed circRNAs between tumor and normal tissues. Table S2: differentially expressed miRNAs between tumor and normal tissues. (Supplementary Materials)
- L. A. Torre, F. Bray, R. L. Siegel, J. Ferlay, and J. Lortet-Tieulent, “Global cancer statistics, 2012,” CA: A Cancer Journal for Clinicians, vol. 65, no. 2, pp. 87–108, 2015.
- J. Park do, N. J. Thomas, C. Yoon, and S. S. Yoon, “Vascular endothelial growth factor a inhibition in gastric cancer,” Gastric Cancer, vol. 18, no. 1, pp. 33–42, 2015.
- P. Karimi, F. Islami, S. Anandasabapathy, N. D. Freedman, and F. Kamangar, “Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention,” Cancer Epidemiology Biomarkers & Prevention, vol. 23, no. 5, pp. 700–713, 2014.
- G. Spolverato, A. Ejaz, Y. Kim et al., “Rates and patterns of recurrence after curative intent resection for gastric cancer: A United States multi-institutional analysis,” Journal of the American College of Surgeons, vol. 219, no. 4, pp. 664–675, 2014.
- X. Qi, Y. Liu, W. Wang et al., “Management of advanced gastric cancer: An overview of major findings from meta-analysis,” Oncotarget , vol. 7, no. 47, pp. 78180–78205, 2016.
- J. E. Wilusz and P. A. Sharp, “A circuitous route to noncoding RNA,” Science, vol. 340, no. 6131, pp. 440-441, 2013.
- W. R. Jeck, J. A. Sorrentino, K. Wang et al., “Circular RNAs are abundant, conserved, and associated with ALU repeats,” RNA, vol. 19, no. 2, pp. 141–157, 2013.
- S. Memczak, M. Jens, A. Elefsinioti et al., “Circular RNAs are a large class of animal RNAs with regulatory potency,” Nature, vol. 495, no. 7441, pp. 333–338, 2013.
- Y.-G. Zhang, H.-L. Yang, Y. Long, and W.-L. Li, “Circular RNA in blood corpuscles combined with plasma protein factor for early prediction of pre-eclampsia,” BJOG: An International Journal of Obstetrics & Gynaecology, vol. 123, no. 13, pp. 2113–2118, 2016.
- Y. Li, Q. Zheng, C. Bao et al., “Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis,” Cell Research, vol. 25, no. 8, pp. 981–984, 2015.
- J. Guarnerio, M. Bezzi, J. C. Jeong et al., “Oncogenic Role of Fusion-circRNAs Derived from Cancer-Associated Chromosomal Translocations,” Cell, vol. 165, pp. 289–302, 2016.
- X. Wang, Y. Zhang, L. Huang et al., “Decreased expression of hsa_circ_001988 in colorectal cancer and its clinical significances,” International Journal of Clinical and Experimental Pathology, vol. 8, no. 12, pp. 16020–16025, 2015.
- M. Qin, G. Liu, X. Huo et al., “Hsa_circ_0001649: a circular RNA and potential novel biomarker for hepatocellular carcinoma,” Cancer Biomarkers, vol. 16, no. 1, pp. 161–169, 2016.
- L. Xuan, L. Qu, H. Zhou et al., “Circular RNA: a novel biomarker for progressive laryngeal cancer,” American Journal of Translational Research, vol. 8, no. 2, pp. 932–939, 2016.
- X. Song, N. Zhang, P. Han et al., “Circular RNA profile in gliomas revealed by identification tool UROBORUS,” Nucleic Acids Research, vol. 44, no. 9, article no. e87, 2016.
- H. L. Sanger, G. Klotz, D. Riesner, H. J. Gross, and A. K. Kleinschmidt, “Viroids are single stranded covalently closed circular RNA molecules existing as highly base paired rod like structures,” Proceedings of the National Acadamy of Sciences of the United States of America, vol. 73, no. 11, pp. 3852–3856, 1976.
- W. W. Du, L. Fang, W. Yang et al., “Induction of tumor apoptosis through a circular RNA enhancing Foxo3 activity,” Cell Death & Differentiation, vol. 24, no. 2, pp. 357–370, 2017.
- M. Armakola, M. J. Higgins, M. D. Figley et al., “Inhibition of RNA lariat debranching enzyme suppresses TDP-43 toxicity in ALS disease models,” Nature Genetics, vol. 44, no. 12, pp. 1302–1309, 2012.
- Z. Li, C. Huang, C. Bao et al., “Exon-intron circular RNAs regulate transcription in the nucleus,” Nature Structural & Molecular Biology, vol. 22, no. 3, pp. 256–264, 2015.
- R. Ashwal-Fluss, M. Meyer, N. R. Pamudurti et al., “CircRNA biogenesis competes with pre-mRNA splicing,” Molecular Cell, vol. 56, no. 1, pp. 55–66, 2014.
- W. W. Du, W. Yang, E. Liu, Z. Yang, P. Dhaliwal, and B. B. Yang, “Foxo3 circular RNA retards cell cycle progression via forming ternary complexes with p21 and CDK2,” Nucleic Acids Research, vol. 44, no. 6, pp. 2846–2858, 2016.
- A. J. Enright, B. John, U. Gaul, T. Tuschl, C. Sander, and D. S. Marks, “MicroRNA targets in Drosophila,” Genome Biology, vol. 5, no. 1, 2003.
- A. E. Pasquinelli, “MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship,” Nature Reviews Genetics, vol. 13, no. 4, pp. 271–282, 2012.
- I. S. Vlachos, M. D. Paraskevopoulou, D. Karagkouni et al., “DIANA-TarBase v7.0: indexing more than half a million experimentally supported miRNA:mRNA interactions,” Nucleic Acids Research, vol. 43, no. 1, pp. D153–D159, 2015.
- G. Bindea, B. Mlecnik, H. Hackl et al., “ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks,” Bioinformatics, vol. 25, no. 8, pp. 1091–1093, 2009.
- G. Bindea, J. Galon, and B. Mlecnik, “CluePedia Cytoscape plugin: pathway insights using integrated experimental and in silico data,” Bioinformatics, vol. 29, no. 5, pp. 661–663, 2013.
- G. Scardoni, M. Petterlini, and C. Laudanna, “Analyzing biological network parameters with CentiScaPe,” Bioinformatics, vol. 25, no. 21, pp. 2857–2859, 2009.
- M. B. Assumpcao, F. C. Moreira, I. G. Hamoy et al., “High-throughput miRNA sequencing reveals a field effect in gastric cancer and suggests an epigenetic network mechanism,” Bioinformatics and Biology Insights, vol. 9, pp. 111–117, 2015.
- O. Yang, J. Huang, and S. Lin, “Regulatory effects of miRNA on gastric cancer cells,” Oncology Letters, vol. 8, no. 2, pp. 651–656, 2014.
- S. Meng, H. Zhou, Z. Feng et al., “CircRNA: Functions and properties of a novel potential biomarker for cancer,” Molecular Cancer, vol. 16, no. 1, article no. 94, 2017.
- L. Chen, S. Zhang, J. Wu et al., “CircRNA-100290 plays a role in oral cancer by functioning as a sponge of the MIR-29 family,” Oncogene, vol. 36, no. 32, pp. 4551–4561, 2017.
- A. Saxena, S. K. Shukla, K. N. Prasad, and U. C. Ghoshal, “Analysis of p53, K-ras gene mutation Helicobacter pylori infection in patients with gastric cancer peptic ulcer disease at a tertiary care hospital in north India,” Indian Journal of Medical Research, vol. 136, pp. 664–670, 2012.
- S. Uchino, M. Noguchi, A. Ochiai, T. Saito, M. Kobayashi, and S. Hirohashi, “p53 mutation in gastric cancer: a genetic model for carcinogenesis is common to gastric and colorectal cancer,” International Journal of Cancer, vol. 54, no. 5, pp. 759–764, 1993.
- J. He, G. Zhu, L. Gao et al., “Fra-1 is upregulated in gastric cancer tissues and affects the PI3K/Akt and p53 signaling pathway in gastric cancer,” International Journal of Oncology, vol. 47, no. 5, pp. 1725–1734, 2015.
- T. Zheng, J. Wang, H. Jiang, and L. Liu, “Hippo signaling in oval cells and hepatocarcinogenesis,” Cancer Letters, vol. 302, no. 2, pp. 91–99, 2011.
- L. Zhang, X. Liu, H. Jin et al., “MiR-206 inhibits gastric cancer proliferation in part by repressing CyclinD2,” Cancer Letters, vol. 332, no. 1, pp. 94–101, 2013.
- H. Shi, J. Han, S. Yue, T. Zhang, W. Zhu, and D. Zhang, “Prognostic significance of combined microRNA-206 and CyclinD2 in gastric cancer patients after curative surgery: A retrospective cohort study,” Biomedicine & Pharmacotherapy, vol. 71, pp. 210–215, 2015.
- D. W. Thomson and M. E. Dinger, “Endogenous microRNA sponges: evidence and controversy,” Nature Reviews Genetics, vol. 17, no. 5, pp. 272–283, 2016.
- L. Salmena, L. Poliseno, Y. Tay, L. Kats, and P. P. Pandolfi, “A ceRNA hypothesis: the rosetta stone of a hidden RNA language?” Cell, vol. 146, no. 3, pp. 353–358, 2011.
- X. Bao, T. Ren, Y. Huang et al., “Knockdown of long non-coding RNA HOTAIR increases miR-454-3p by targeting Stat3 and Atg12 to inhibit chondrosarcoma growth,” Cell Death & Disease, vol. 8, no. 2, pp. e2605–e2605, 2017.
- N. Shao, L. Wang, L. Xue, R. Wang, and Q. Lan, “Plasma miR-454-3p as a potential prognostic indicator in human glioma,” Neurological Sciences, vol. 36, no. 2, pp. 309–313, 2015.
Copyright © 2018 Wei Gu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.